• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: Post-transcriptional modifications in cancer immunity and immunotherapy.

作者信息

Wei Gaigai, Zhou Yufeng, Yue Tao, Zhang Duanwu

机构信息

Children's Hospital of Fudan University, National Children's Medical Center, and Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, Shanghai, China.

National Health Commission (NHC) Key Laboratory of Neonatal Diseases, Fudan University, Shanghai, China.

出版信息

Front Immunol. 2025 Aug 21;16:1680859. doi: 10.3389/fimmu.2025.1680859. eCollection 2025.

DOI:10.3389/fimmu.2025.1680859
PMID:40918121
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12408273/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e03b/12408273/7cad10245fb8/fimmu-16-1680859-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e03b/12408273/7cad10245fb8/fimmu-16-1680859-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e03b/12408273/7cad10245fb8/fimmu-16-1680859-g001.jpg

相似文献

1
Editorial: Post-transcriptional modifications in cancer immunity and immunotherapy.社论：癌症免疫与免疫治疗中的转录后修饰
Front Immunol. 2025 Aug 21;16:1680859. doi: 10.3389/fimmu.2025.1680859. eCollection 2025.
2
The role of RNA methylation in tumor immunity and its potential in immunotherapy.RNA 甲基化在肿瘤免疫中的作用及其在免疫治疗中的潜力。
Mol Cancer. 2024 Jun 20;23(1):130. doi: 10.1186/s12943-024-02041-8.
3
SpliceMutr Enables Pan-Cancer Analysis of Splicing-Derived Neoantigen Burden in Tumors.SpliceMutr可实现对肿瘤中剪接衍生新抗原负荷的泛癌分析。
Cancer Res Commun. 2024 Dec 1;4(12):3137-3150. doi: 10.1158/2767-9764.CRC-23-0309.
4
N6-methyladenosine RNA methylation, a new hallmark of metabolic reprogramming in the immune microenvironment.N6-甲基腺苷RNA甲基化，免疫微环境中代谢重编程的一个新标志。
Front Immunol. 2024 Dec 20;15:1464042. doi: 10.3389/fimmu.2024.1464042. eCollection 2024.
5
m6A RNA methylation: a pivotal regulator of tumor immunity and a promising target for cancer immunotherapy.m6A RNA甲基化：肿瘤免疫的关键调节因子及癌症免疫治疗的潜在靶点
J Transl Med. 2025 Feb 28;23(1):245. doi: 10.1186/s12967-025-06221-y.
6
Molecular phenotypic linkage between N-methyladenosine methylation and tumor immune microenvironment in hepatocellular carcinoma.肝细胞癌中 N6-甲基腺苷甲基化与肿瘤免疫微环境的分子表型关联。
J Cancer Res Clin Oncol. 2023 Aug;149(10):6901-6916. doi: 10.1007/s00432-023-04589-2. Epub 2023 Feb 24.
7
Downregulation of HNRNPA1 induced neoantigen generation via regulating alternative splicing.HNRNPA1的下调通过调节可变剪接诱导新抗原的产生。
Mol Med. 2024 Jun 12;30(1):85. doi: 10.1186/s10020-024-00849-0.
8
Reversing the "cold" tumor microenvironment: the role of neoantigen vaccines in prostate cancer.逆转“冷”肿瘤微环境：新抗原疫苗在前列腺癌中的作用
J Transl Med. 2025 Jul 25;23(1):835. doi: 10.1186/s12967-025-06867-8.
9
DNA methylation-related lncRNAs predict prognosis and immunotherapy response in gastric cancer.DNA 甲基化相关长链非编码 RNA 预测胃癌的预后和免疫治疗反应。
J Cancer Res Clin Oncol. 2023 Nov;149(16):14745-14760. doi: 10.1007/s00432-023-05234-8. Epub 2023 Aug 17.
10
Antitumor effect of neoantigen-reactive T cells combined with PD1 inhibitor therapy in mouse lung cancer.T 细胞结合 PD1 抑制剂治疗在小鼠肺癌中的抗肿瘤作用。
J Cancer Res Clin Oncol. 2023 Aug;149(10):7363-7378. doi: 10.1007/s00432-023-04683-5. Epub 2023 Mar 18.

本文引用的文献

1
The role of RNA methylation in tumor immunity and its potential in immunotherapy.RNA 甲基化在肿瘤免疫中的作用及其在免疫治疗中的潜力。
Mol Cancer. 2024 Jun 20;23(1):130. doi: 10.1186/s12943-024-02041-8.
2
ADP-ribosylation from molecular mechanisms to therapeutic implications.ADP-核糖基化：从分子机制到治疗意义。
Cell. 2023 Oct 12;186(21):4475-4495. doi: 10.1016/j.cell.2023.08.030.
3
RNA splicing dysregulation and the hallmarks of cancer.RNA 剪接失调与癌症的特征。
Nat Rev Cancer. 2023 Mar;23(3):135-155. doi: 10.1038/s41568-022-00541-7. Epub 2023 Jan 10.
4
Impacts and mechanisms of alternative mRNA splicing in cancer metabolism, immune response, and therapeutics.非经典 mRNA 剪接在癌症代谢、免疫反应和治疗中的影响和机制。
Mol Ther. 2022 Mar 2;30(3):1018-1035. doi: 10.1016/j.ymthe.2021.11.010. Epub 2021 Nov 15.
5
Post-transcriptional gene regulation by mRNA modifications.mRNA修饰介导的转录后基因调控。
Nat Rev Mol Cell Biol. 2017 Jan;18(1):31-42. doi: 10.1038/nrm.2016.132. Epub 2016 Nov 3.
6
Messenger RNA modifications: Form, distribution, and function.信使 RNA 修饰：形式、分布和功能。
Science. 2016 Jun 17;352(6292):1408-12. doi: 10.1126/science.aad8711.
7
RNA splicing factors as oncoproteins and tumour suppressors.作为癌蛋白和肿瘤抑制因子的RNA剪接因子
Nat Rev Cancer. 2016 Jul;16(7):413-30. doi: 10.1038/nrc.2016.51. Epub 2016 Jun 10.
8
The spliceosome as a target of novel antitumour drugs.剪接体作为新型抗肿瘤药物的靶标。
Nat Rev Drug Discov. 2012 Nov;11(11):847-59. doi: 10.1038/nrd3823.